Compare $BCLI vs $XCUR | Chartloom

Compare

$BCLI vs $XCUR

Brainstorm Cell Therapeutics Inc · Exicure Inc

BCLI

Brainstorm Cell Therapeutics Inc

XCUR

Exicure Inc

Compare $BCLI vs $XCUR

Comparing Brainstorm Cell Therapeutics Inc and Exicure Inc

BCLIBrainstorm Cell Therapeutics Inc

XCURExicure Inc

BCLIBrainstorm Cell Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

54.9%

52W performance

30.1%

FCF yield

-21.1%

XCURExicure Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-80.3%

FCF yield

-105.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCLI

XCUR

Detailed metrics comparison

BCLI

Brainstorm Cell Therapeutics Inc

XCUR

Exicure Inc

Market Cap

BCLI$10M

XCUR$7M

Enterprise Value

BCLI$12M

XCUR$5M

Price

BCLI$0.95

XCUR$1.05

P/E Ratio

BCLIN/A

XCURN/A

P/S Ratio

BCLI0.00x

XCUR14.24x

EV/Sales

BCLI0.00x

XCUR10.81x

EV/EBITDA

BCLI0.00x

XCUR0.90x

P/B Ratio

BCLI7.31x

XCUR7.29x

P/FCF Ratio

BCLIN/A

XCURN/A

EV/FCF

BCLI-5.29x

XCUR-0.71x

PEG Ratio

BCLIN/A

XCURN/A

Forward P/E (NTM)

BCLIN/A

XCURN/A

Forward P/S (NTM)

BCLIN/A

XCURN/A

Revenue (TTM)

BCLI$0

XCUR$0

Revenue Growth (YoY)

BCLIN/A

XCURN/A

Forward Rev Growth

BCLI53.7%

XCUR0.0%

Gross Margin (TTM)

BCLI0.0%

XCUR0.0%

Operating Margin (TTM)

BCLI0.0%

XCUR0.0%

EBITDA Margin (TTM)

BCLI0.0%

XCUR0.0%

Net Margin (TTM)

BCLI0.0%

XCUR0.0%

FCF Margin (TTM)

BCLIN/A

XCURN/A

Net Income (TTM)

BCLI$-7M

XCUR$-8M

FCF (TTM)

BCLI$-2M

XCUR$-7M

EPS (TTM)

BCLI-$0.61

XCUR-$1.30

ROE (TTM)

BCLI-23636.0%

XCUR-23791.0%

ROA (TTM)

BCLI-33822.0%

XCUR-6198.0%

ROIC (TTM)

BCLI-23636.0%

XCUR-23791.0%

Cash

BCLI$22K

XCUR$2M

Debt

BCLI$1M

XCUR$0

Net Cash/Debt

BCLI$-1M

XCUR$2M

Current Ratio (TTM)

BCLI0.21x

XCUR0.56x

Quick Ratio (TTM)

BCLI0.16x

XCUR0.43x

Debt/Equity (TTM)

BCLI0.00x

XCUR0.00x

Debt/Assets (TTM)

BCLI0.0%

XCUR0.0%

Interest Coverage (TTM)

BCLIN/A

XCURN/A

Net Debt/EBITDA (TTM)

BCLI0.00x

XCUR0.00x

Beta

BCLI0.39

XCUR3.86

52W Performance

BCLI30.1%

XCUR-80.3%

YTD Performance

BCLI54.9%

XCUR-81.2%

% from 52W High

BCLI-43.8%

XCUR-88.9%

% from 52W Low

BCLI106.9%

XCUR12.2%

Asset Turnover (TTM)

BCLI0.00x

XCUR0.05x

FCF Yield (TTM)

BCLI-21.1%

XCUR-105.0%

Earnings Yield (TTM)

BCLI-64.2%

XCUR-123.9%

Dividend Yield (TTM)

BCLIN/A

XCURN/A

Rule of 40

BCLI0.0

XCUR0.0

EV/GP/RG

BCLIN/A

XCURN/A

Ticker research

View BCLI research View XCUR research

Metric	BCLI Brainstorm Cell Therapeutics Inc	XCUR Exicure Inc
Market & Valuation
Market Cap	$10M	$7M
Enterprise Value	$12M	$5M
Price	$0.95	$1.05
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	14.24x
EV/Sales	0.00x	10.81x
EV/EBITDA	0.00x	0.90x
P/B Ratio	7.31x	7.29x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.29x	-0.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	53.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-7M	$-8M
FCF (TTM)	$-2M	$-7M
EPS (TTM)	-$0.61	-$1.30
ROE (TTM)	-23636.0%	-23791.0%
ROA (TTM)	-33822.0%	-6198.0%
ROIC (TTM)	-23636.0%	-23791.0%
Financial Health
Cash	$22K	$2M
Debt	$1M	$0
Net Cash/Debt	$-1M	$2M
Current Ratio (TTM)	0.21x	0.56x
Quick Ratio (TTM)	0.16x	0.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	3.86
52W Performance	30.1%	-80.3%
YTD Performance	54.9%	-81.2%
% from 52W High	-43.8%	-88.9%
% from 52W Low	106.9%	12.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-21.1%	-105.0%
Earnings Yield (TTM)	-64.2%	-123.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCLI research	View XCUR research

Valuation

P/S Ratio

BCLI

0.00x

XCUR

14.24x

EV/FCF

BCLI

-5.29x

XCUR

-0.71x

Growth & revenue

Forward Revenue Growth

BCLI

53.7%

XCUR

0.0%

Profitability & performance

Gross Margin

BCLI

0.0%

XCUR

0.0%

ROE

BCLI

-23636.0%

XCUR

-23791.0%

FCF Yield %

BCLI

-21.1%

XCUR

-105.0%

52-Week Performance

BCLI

30.1%

XCUR

-80.3%

Detailed metrics comparison

BCLI

Brainstorm Cell Therapeutics Inc

XCUR

Exicure Inc

Market Cap

BCLI$10M

XCUR$7M

Enterprise Value

BCLI$12M

XCUR$5M

Price

BCLI$0.95

XCUR$1.05

P/E Ratio

BCLIN/A

XCURN/A

P/S Ratio

BCLI0.00x

XCUR14.24x

EV/Sales

BCLI0.00x

XCUR10.81x

EV/EBITDA

BCLI0.00x

XCUR0.90x

P/B Ratio

BCLI7.31x

XCUR7.29x

P/FCF Ratio

BCLIN/A

XCURN/A

EV/FCF

BCLI-5.29x

XCUR-0.71x

PEG Ratio

BCLIN/A

XCURN/A

Forward P/E (NTM)

BCLIN/A

XCURN/A

Forward P/S (NTM)

BCLIN/A

XCURN/A

Revenue (TTM)

BCLI$0

XCUR$0

Revenue Growth (YoY)

BCLIN/A

XCURN/A

Forward Rev Growth

BCLI53.7%

XCUR0.0%

Gross Margin (TTM)

BCLI0.0%

XCUR0.0%

Operating Margin (TTM)

BCLI0.0%

XCUR0.0%

EBITDA Margin (TTM)

BCLI0.0%

XCUR0.0%

Net Margin (TTM)

BCLI0.0%

XCUR0.0%

FCF Margin (TTM)

BCLIN/A

XCURN/A

Net Income (TTM)

BCLI$-7M

XCUR$-8M

FCF (TTM)

BCLI$-2M

XCUR$-7M

EPS (TTM)

BCLI-$0.61

XCUR-$1.30

ROE (TTM)

BCLI-23636.0%

XCUR-23791.0%

ROA (TTM)

BCLI-33822.0%

XCUR-6198.0%

ROIC (TTM)

BCLI-23636.0%

XCUR-23791.0%

Cash

BCLI$22K

XCUR$2M

Debt

BCLI$1M

XCUR$0

Net Cash/Debt

BCLI$-1M

XCUR$2M

Current Ratio (TTM)

BCLI0.21x

XCUR0.56x

Quick Ratio (TTM)

BCLI0.16x

XCUR0.43x

Debt/Equity (TTM)

BCLI0.00x

XCUR0.00x

Debt/Assets (TTM)

BCLI0.0%

XCUR0.0%

Interest Coverage (TTM)

BCLIN/A

XCURN/A

Net Debt/EBITDA (TTM)

BCLI0.00x

XCUR0.00x

Beta

BCLI0.39

XCUR3.86

52W Performance

BCLI30.1%

XCUR-80.3%

YTD Performance

BCLI54.9%

XCUR-81.2%

% from 52W High

BCLI-43.8%

XCUR-88.9%

% from 52W Low

BCLI106.9%

XCUR12.2%

Asset Turnover (TTM)

BCLI0.00x

XCUR0.05x

FCF Yield (TTM)

BCLI-21.1%

XCUR-105.0%

Earnings Yield (TTM)

BCLI-64.2%

XCUR-123.9%

Dividend Yield (TTM)

BCLIN/A

XCURN/A

Rule of 40

BCLI0.0

XCUR0.0

EV/GP/RG

BCLIN/A

XCURN/A

Ticker research

View BCLI research View XCUR research

Metric	BCLI Brainstorm Cell Therapeutics Inc	XCUR Exicure Inc
Market & Valuation
Market Cap	$10M	$7M
Enterprise Value	$12M	$5M
Price	$0.95	$1.05
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	14.24x
EV/Sales	0.00x	10.81x
EV/EBITDA	0.00x	0.90x
P/B Ratio	7.31x	7.29x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.29x	-0.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	53.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-7M	$-8M
FCF (TTM)	$-2M	$-7M
EPS (TTM)	-$0.61	-$1.30
ROE (TTM)	-23636.0%	-23791.0%
ROA (TTM)	-33822.0%	-6198.0%
ROIC (TTM)	-23636.0%	-23791.0%
Financial Health
Cash	$22K	$2M
Debt	$1M	$0
Net Cash/Debt	$-1M	$2M
Current Ratio (TTM)	0.21x	0.56x
Quick Ratio (TTM)	0.16x	0.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	3.86
52W Performance	30.1%	-80.3%
YTD Performance	54.9%	-81.2%
% from 52W High	-43.8%	-88.9%
% from 52W Low	106.9%	12.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-21.1%	-105.0%
Earnings Yield (TTM)	-64.2%	-123.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCLI research	View XCUR research